The U.S. FDA has approved Palforzia, the oral immunotherapy (OIT) for peanut allergy, for treatment in toddlers with peanut allergy. … Read more »
Tag: peanut oit
In Toddlers, OIT Can Lead to Peanut Allergy Remission: Study
Treatment of young toddlers with peanut oral immunotherapy (OIT) may be the key to inducing remission of peanut allergy, a… Read more »
Europe’s Palforizia OIT Study Shows Speed of Desensitization
Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Palforzia OIT Study Sees Maturing of Immune System Over Time
A study found encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial participants… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »
FDA Approves Aimmune’s Palforzia OIT, Coming Soon to Allergist Clinics
The Food and Drug Administration on Jan. 31, 2020 approved Palforzia, Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for peanut allergy… Read more »
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
Longer Trial Increased Level of Tolerance to AR101 Peanut Therapy
By extending the peanut biologic oral immunotherapy known as AR101 by 28 weeks, a new study finds that a majority… Read more »
OIT More Successful in Babies, New Study Finds
Testing OIT in such a young population has never been done before, but results show that it’s worth it.